probiome Sign in
← Conditions Metabolism and nutrition Genus-level

High cholesterol

Compared within 1 study that had both: 27 people with high cholesterol and 30 healthy people. No genera less common in people with high cholesterol, and none more common.

A difference is an association: it doesn’t mean these genera cause, prevent or treat high cholesterol. GMrepo reports this group at the genus level only, so these are genera, not species.

Searching opens both lists and shows only matching rows.

Less common in high cholesterol · 0

Strongest first, then the biggest gap · Each figure is 10 people Strongest first · Each figure is 10 people

None compared.

More common in high cholesterol · 0

Strongest first, then the biggest gap · Each figure is 10 people Strongest first · Each figure is 10 people

None compared.

Where these numbers come from

Studies
Only GMrepo projects that had people with the condition and healthy people, 10 or more of each. Numbers come from those studies, never from pooling.Sampled in Chile.
How common
The share of people whose sample has any of it, in the people with the condition and in the healthy people of those same studies. Tested within studies (Cochran–Mantel–Haenszel, corrected for testing many microbes); a difference counts when it is clear and meaningful (Cohen’s h of 0.2 or more).
Strength word
Counted by code from how many studies point the same way: Seen again and again (3 or more, none clearly the other way), Seen more than once (2, the majority), Seen once (1, listed last). Where studies disagree, a row isn’t listed.
Each study
Tap a row for every study’s own numbers, and for how much carriers have.
Analysis
Our analysis of GMrepo data. GMrepo on Data sources · Read the rules

Also compared · 76 genera

Compared within studies that had both, but not listed above.

No meaningful difference · 76
PubMed · human studies and reviews first

Recent research

All research on it
  1. Randomized trial Nutricion hospitalaria · 2025
    Effects of probiotic supplementation on blood lipids ın hypercholesterolemic obese patients: a randomized, double-blind, placebo-controlled pilot trial.
    PubMed ↗
  2. Randomized trial NPJ biofilms and microbiomes · 2022
    Gut microbiome responses to dietary intervention with hypocholesterolemic vegetable oils.
    PubMed ↗
  3. Review Endocrine, metabolic & immune disorders drug targets · 2022
    In vitro Cholesterol Assimilation by Bifidobacterium animalis subsp. lactis (BPL1) Probiotic Bacteria Under Intestinal Conditions.
    PubMed ↗
  4. Randomized trial Frontiers in immunology · 2021
    The Prebiotic Effects of Oats on Blood Lipids, Gut Microbiota, and Short-Chain Fatty Acids in Mildly Hypercholesterolemic Subjects Compared With Rice: A Randomized, Controlled Trial.
    PubMed ↗
  5. Randomized trial Nutrients · 2021
    Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (Bifidobacterium longum BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study).
    PubMed ↗

Source: PubMed, U.S. National Library of Medicine · 22 linked papers, last 10 years